Treatment, outcomes and costs of asthma exacerbations in Chilean children: a prospective multicenter observational study
Main Article Content
Keywords
Asthma hospitalization, Asthma exacerbation treatment
Abstract
Objective: To describe potential regional variations in therapies for severe asthma exacerbations in Chilean children and estimate the associated health expenditures.
Methods: Observational prospective cohort study in 14 hospitals over a one-year period. Children five years of age or older were eligible for inclusion. Days with oxygen supply and pharmacological treatments received were recorded from the clinical chart. A basic asthma hospitalization basket was defined in order to estimate the average hospitalization cost for a single patient. Six months after discharge, new visits to the Emergency Room (ER), use of systemic corticosteroids and adherence to the controller treatment were evaluated.
Results: 396 patients were enrolled. Patients from the public health system and from the north zone received significantly more days of oxygen, systemic corticosteroids and antibiotics. Great heterogeneity in antibiotic use among the participating hospitals was found, from 0 to 92.3% (ICC 0.34, 95% CI 0.16-0.52). The use of aminophylline, magnesium sulfate and ketamine varied from 0 to 36.4% between the different Pediatric Intensive Care Units (ICC 0.353, 95% CI 0.010-0.608). The average cost per inpatient was of $1910 USD. 290 patients (73.2%) completed the follow-up six months after discharge. 76 patients (26.2%) were not receiving any controller treatment and nearly a fourth had new ER visits and use of systemic corticosteroids due to new asthma exacerbations.
Conclusions: Considerable practice variation in asthma exacerbations treatment was found among the participating hospitals, highlighting the poor outcome of many patients after hospital discharge, with an important health cost.
References
2. Herrera AM, Cavada G, Manalich ˜ J. Hospitalizaciones por asma infantil en Chile: 2001---2014. Rev Chil Pediatr. 2017;88:602-7.
3. Herrera AM, Brand P, Cavada G, Koppmann A, Rivas M, Mackenney J, et al. Hospitalizations for asthma exacerbation in Chilean children: a multicenter observational study. Allergol Immunopathol (Madr). 2018:S0301-546, 30049-1.
4. Estudio de costos de prestaciones de salud 2011. FONASA 2012 https://pornuestrasalud.files.wordpress.com/2012/10/presentacic3b3nfonasa 20120829 cc.pdf (accessed in December 2017).
5. Aravena P, Inostroza M. ¿Salud pública o privada? Los factores mas importantes al evaluar el sistema de salud en Chile. Rev Med Chil. 2015;143:244---51. http://www.ine.cl/estadisticas/demograficas-y-vitales (accessed in October 2017).
6. http://www.ine.cl/estadisticas/demograficas-y-vitales (accessed in October 2017).
7. Parikh K, Hall M, Mittal V, Moltalbano A, Mussman M, Morse RB, et al. Establishing benchmarks for the hospitalized care of children with asthma, bronchiolitis and pneumonia. Pediatrics. 2014;134:555-62.
8. Graham V, Lasserson TJ, Rowe BH. Antibiotics for acute asthma. Cochrane Database Syst Rev. 2001:CDOO2741.
9. Muhammed S, Joshi D. Antibiotics in children with bronchial asthma. Int J Contemp Pediatr. 2017;4:843-7.
10. GINA 2018. http://ginasthma.org/2017-gina-report-globalstrategy-for-asthma-management-and-prevention/ (accessed in April 2018).
11. Bratton SL, Odetola FO, McCollegan J, Cabana MD, Levy FH, Keenan HT. Regional variation in ICU care for pediatric patients with asthma. J Pediatr. 2005;147:355-61.
12. Al-Eyadhy AA, Temsah M-H, Alhaboob AAN, Aldubayan AK, Almousa AN, Alsharidah AM, et al. Asthma changes at a pediatric intensive care unit after 10 years: observational study. Annals Thoracic Med. 2015;10:243-8.
13. Dilley MA, Sheehan WJ, Petty CR, Gaffin JM, Hauptman M, Phipatanakul W. Comparison of treatment modalities for inpatient asthma exacerbations among US pediatric hospitals. J Allergy Clin Immunol Pract. 2017;5:855-7.
14. Travers AH, Milan SJ, Jones AP, Camargo CA Jr, Rowe BH. Addition of intravenous beta(2)-agonists to inhaled beta(2)- agonists for acute asthma. Cochrane Database Syst Rev. 2012;12:CD010179.
15. Castro-Rodriguez JA, Rodrigo GJ, Rodriguez-Martínez CE. Principal findings of systematic reviews of acute treatment in childhood. J Asthma. 2015;52:407-16.
16. Korang SK, Feinberg J, Wetterslev J, Jakobsen JC. Non-invasive positive pressure ventilation for acute asthma in children. Cochrane Database Syst Rev. 2016;9:CD012067.
17. Jones BP, Fleming GM, Otillio, Asokan I, Arnold DH. Pediatric acute asthma exacerbations: evaluation and management from emergency department to intensive care unit. J Asthma. 2016;53:607-17.
18. Loh LE, Chan YH, Chan I. Noninvasive ventilation in children: a review. J Pediatr (Rio J). 2007;83 2 Suppl.:S91-9.
19. Coralloa AN, Croxforda R, Goodmand DC, Bryand EL, Srivastavac D, Stukel TA. A systematic review of medical practice variation in OECD countries. Health Policy. 2014;114: 5-14.
20. Wishaupt JO, Russcher A, Smeets LC, Versteegh FG, Hartwig NG. Clinical impact of RT-PCR for pediatric acute respiratory infections: a controlled clinical trial. Pediatrics. 2011;128, e1113-20.
21. British guideline on the management of asthma. https://www.brit-thoracic.org.uk/document-library/clinical-information/asthma/btssign-asthma-guideline-2016/ (accessed in April 2018).
22. https://reportesdeis.minsal.cl/egresoshospitalarios/menupublica nueva/menu publica nueva.htm (accessed in December 2017).
23. O’Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med. 2009;179:19-24.
24. Herrera AM, Fitzgerald DA. Question 1: why do children still die from asthma? Paediatr Respir Rev. 2018:S1526-42, 30007-1.
25. Lasmar L, Fontes MJ, Mohallen MT, Fonseca AC, Camargos P. Wheezy child program: the experience of the belo Horizonte pediatric asthma management program. World Allergy Org J. 2009;2:289-95.
26. Haahtela T, Valovirta E, Bousquet J, Mäkelä M, and the Allergy Programme Steering Group. The Finnish Allergy Programme 2008-2018 works. Eur Respir J. 2017;49.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.